David H McDermott
National Institute of Allergy and Infectious Diseases (NIAID)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David H McDermott as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:25 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05078879 · Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 DeficiencyNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Crohn's Disease, Glycogen Metabolism, Inflammatory Bowel Disease (IBD) · principal investigator
- Ph2/Ph3NCT02231879 · Plerixafor Versus G-CSF in the Treatment of People With WHIM SyndromeNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Myelokathexis, Infections, Neutropenia · principal investigator
- Ph1/Ph2NCT00967785 · A Phase I Study of Mozobil in the Treatment of Patients With WHIMSNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Leukopenia, Neutropenia, Infections · principal investigator
- N/ANCT00359307 · Genetic Factors in AtherosclerosisNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Atherosclerosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:25 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- 117 citationsRCR 3.2
- 112 citationsRCR 2.8
- Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.AIDS · 200079 citationsRCR 1.7
- SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation.Blood · 202148 citationsRCR 2.7
- A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.J Clin Invest · 202345 citationsRCR 4.1
- Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome.J Clin Immunol · 2026